Boehringer Ingelheim, a global leader in preventive medicines for livestock, obtained positive opinions by the European Medicines Agency (EMA) recommending the granting of marketing authorisations under exceptional circumstances2 for its avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5. Both vaccines immunize birds against the H5 avian influenza virus, which is currently causing outbreaks across Europe.
LAS VEGAS, May 15, 2026 (GLOBE NEWSWIRE) -- LV Petroleum LLC this week reaffirmed its commitment to two critical pillars of its business – cultivating roots in the communities it serves and responsibly growing its national footprint. In the same week, the transportation company sponsored a local charity football game honoring Las Vegas’ first responders…
DUBAI, United Arab Emirates, May 15, 2026 (GLOBE NEWSWIRE) -- COAR has expanded its public rollout by publishing its official Solana contract address and highlighting active early-stage roadmap milestones on its website, giving market participants a clearer reference point as interest in commodity-themed digital assets continues to build.
WHITE PLAINS, N.Y., May 15, 2026 (GLOBE NEWSWIRE) -- Momentous Holdings Corp. (OTC: MMNT) (the “Company”) today provided a strategic business update regarding its planned entry into the international trading, distribution, and related operations of small home appliance products.
DUBLIN, Ireland, May 15, 2026 (GLOBE NEWSWIRE) -- JPMorgan ETFs (Ireland) ICAV RE: Dividends The Directors of JPMorgan ETFs (Ireland) ICAV (the “Company”) wish to announce the following dividends which are ex dividend as of the 21 May 2026, record date as of the 22 May 2026 & payment date is the 05 June 2026:
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION
